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Abstract
Sin Nombre virus (SNV) is a major representative of the New World hantaviruses and the most common cause of hantavirus pulmonary
syndrome (HPS) with high mortality in North America. Unlike other members of the family Bunyaviridae which mature in the Golgi
complex, New World hantaviruses have been previously reported to mature at the cell surface. For family Bunyaviridae viruses, retention
of the viral glycoproteins at the Golgi complex is thought to be responsible for their Golgi maturation. In our studies, the majority of SNV
glycoproteins, G1 and G2, was localized in the Golgi complex when expressed from a full-length GPC clone or in SNV-infected cells, in
agreement with data for other members of the family Bunyaviridae, including the Old World hantaviruses. However, the SNV glycoproteins
could also be detected at the cell surface at advanced posttransfection or postinfection time points. G1 expressed in the absence of G2 did
not accumulate in the Golgi, but remained predominantly associated with the endoplasmic reticulum (ER). Overexpressed amounts of
apparently misfolded G1 were aggregated in a subcellular compartment likely to represent the aggresome. Unexpectedly, an additional major
pool of G1 was detected intracellularly in SNV-infected and GPC-expressing transfected cells, by using a SNV G1-specific Fab antibody.
This pool of G1 is predominantly localized in late endosomes–lysosomes.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Hantaviruses, family Bunyaviridae, are rodent-borne hu-
man pathogens. Members of the Hantavirus genus are
broadly split into the Old World hantaviruses, which cause
hemorrhagic fever with renal syndrome (HFRS), and the
more recently discovered New World hantaviruses, which
cause hantavirus pulmonary syndrome (HPS) (Nichol,
2001). The prototype strain for the Old World hantaviruses
is Hantaan virus (HTNV). Sin Nombre virus (SNV) is the
major representative of the New World hantaviruses in
North America and the most common etiologic agent of
HPS with high mortality (Nichol et al., 1993). SNV is an
enveloped virus with a tripartite negative-sense RNA ge-
nome. The viral genome encodes the nucleocapsid N pro-
tein, the glycoprotein precursor GPC (which is cotransla-
tionally cleaved by cellular endopeptidases into the two
viral glycoproteins, G1 and G2), and the RNA polymerase
L protein (Lober et al., 2001; Schmaljohn and Hooper,
2001; Schmaljohn et al., 1987).
One of the hallmarks of family Bunyaviridae members is
the unusual property of their maturation at the Golgi appa-
ratus (Jantti et al., 1997; Pettersson and Melin, 1996;
Schmaljohn and Hooper, 2001). The Golgi maturation is
thought to be due to the retention and accumulation of the
two viral glycoproteins G1 and G2 in the Golgi complex
(Pettersson and Melin, 1996). As a consequence, a number
of studies have been done to determine the characteristics of
the glycoproteins that contribute to Golgi retention (Anders-
son et al., 1997a,b; Matsuoka et al., 1994, 1996, 1988). The
glycoprotein closest to the N-terminus of the GPC precursor
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is thought to possess the signal for Golgi localization (Chen
et al., 1991; Pettersson and Melin, 1996). The N-terminal
glycoproteins of two genus phlebovirus members, Punta
Toro and Uukuniemi viruses, are among the most exten-
sively studied. Less is known about the trafficking and
maturation of the glycoproteins of hantaviruses, and studies
to date have been limited to HTNV. In one of those studies,
the HTNV N-terminal glycoprotein G1 was reported to
accumulate in the Golgi complex when expressed alone,
while the G2 protein expressed alone was retained in the
endoplasmic reticulum (ER) (Pensiero and Hay, 1992),
whereas in another, either HTNV G1 or G2 expressed alone
was reported to be retained in the ER (Ruusala et al., 1992).
However, both of these studies reported Golgi localization
of G1 and G2 proteins when the two proteins were coex-
pressed. No detection of expressed hantavirus glycoproteins
at the cell surface have been so far reported.
Earlier studies of hantavirus ultrastructure and matura-
tion based on electron microscopy (EM) also focused on
HTNV (Hung et al., 1985). In those studies, intracellular
maturation of hantaviruses could be observed in cells in-
fected with HTNV, but not as easily as with some other
members of the family Bunyaviridae (e.g., Rift Valley fever
and Uukuniemi viruses) (Schmaljohn and Hooper, 2001).
Recent EM studies of HTNV-infected patient tissues have
also revealed intracellular virus maturation (Wang et al.,
1997).
It was only recently, with the discovery of the New
World hantaviruses, that the intracellular maturation as a
general feature of the hantaviruses has been questioned. EM
studies on SNV and Black Creek Canal virus (BCCV) have
suggested that their maturation did not occur intracellularly
in the Golgi compartment but at the cell surface (Goldsmith
et al., 1995; Ravkov et al., 1997). The suggestion of cell-
surface maturation of the New World hantaviruses was
based on the observation that most of the virus particles
were present extracellularly, with only rare virus-like par-
ticles observed inside the cell (Goldsmith et al., 1995).
These reports, supporting cell-surface maturation of the
New World hantaviruses contrary to the intracellular mat-
uration of the Old World hantaviruses, and the presence of
conflicting reports in the literature on the HTNV G1 local-
ization, prompted the initiation of this study. The main
objectives were to clearly understand the trafficking of SNV
glycoproteins and to gain insights into the virus maturation
process. If the intracellular localization of the glycoproteins
defines the site of virus maturation in the family Bunyaviri-
dae, it was of interest to determine where SNV-expressed
glycoproteins were localized. In addition, if the glycopro-
teins expressed from the GPC precursor colocalize within
the Golgi complex, what is the fate of individually ex-
pressed N-terminal glycoprotein (G1)? Finally, how does
the localization of the expressed glycoproteins correlate
with that observed in SNV-infected cells?
Results
Detection of the G1 and G2 glycoproteins expressed from
individual clones and from the full-length GPC clone
For the expression experiments, HeLa-T4 cells were in-
fected with vTF7-3 and transfected with pGEM-G1, pGEM-
G2, or IRES-GPC constructs. At 12-h posttransfection, cells
were radiolabeled, chased, and immunoprecipitated. Results
of the immunoprecipitation experiments are shown in Fig.
1. The expressed G1 with apparent molecular weight of 75
kDa was precipitated by using the affinity-purified G1-
specific antipeptide antibody (Fig. 1A, lane 2) and the anti-
SNV polyclonal sera (lane 5) and comigrated with authentic
G1 found in SNV-infected Vero-E6 cell lysates (lane 7).
Similarly, expressed G2 with an apparent molecular weight
of 55 kDa was immunoprecipitated by affinity-purified G2-
specific antipeptide antibody (lane 3) and anti-SNV poly-
clonal sera (lane 4) and comigrated with authentic G2 found
in SNV-infected Vero-E6 cell lysates (lane 7). The con-
structed SNV full-length GPC clone was successfully ex-
pressed and correctly processed to G1 and G2 proteins (Fig.
1B). The expressed glycoproteins from the GPC clone were
detected by using the anti-G2 antipeptide antibody (lane 4),
anti-G1 antipeptide antibody (lane 5), and anti-SNV sera
(lane 6). The estimated molecular weights of the processed
G1 and G2 expressed from GPC (lane 7) were in good
accord with those of the G1 and G2 proteins immunopre-
cipitated from SNV-infected Vero-E6 cells (lane 8). In both
cases, however, more G2 than G1 was apparently immuno-
precipitated. This was not due to differences in cysteine (the
amino acid used to radiolabel the proteins) content of the
two proteins as there are 31 and 26 Cysteine residues in G1
and G2, respectively, and similar relative amounts of G1
and G2 are also seen when [35S]Cysteine-Methionine mix-
tures are used as radioactive label (data not shown).
One might expect to detect equimolar amounts of G1 and
G2 based on their processing from the GPC precursor.
Several explanations are possible for the excess of G2
detected in immunoprecipitation experiments. First, the
SNV polyclonal sera may preferentially precipitate G2. Sec-
ond, the possibility exists that in addition to the G2 pro-
cessed from the GPC molecule, additional G2 could be
synthesized as a result of leaky scanning initiation of G2, as
suggested previously for HTNV (Kamrud and Schmaljohn,
1994). Third, the observed results could also be due in part
to formation of G1 multimers, which have a slower mobility
than does the monomeric from, thus shifting much of the G1
protein to a higher position in the gel, away from the
position of the monomeric band. Additional high molecular
weight bands are apparent (Fig. 1B, lane 7) and could
represent G1 or G2 homo- or heterooligomers forming in
the absence of the virus N protein. Such multimers could
also be seen in immunoprecipitation experiments of the
HTNV-expressed G1 (Antic et al., 1992; Hooper et al.,
2001; Pensiero and Hay, 1992). Finally, a preferential deg-
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radation of G1 in lysosomes could occur, as will be dis-
cussed later (see below).
The above results demonstrate that each glycoprotein can
be expressed either individually or from the GPC clone and
yield products of the expected size which can be recognized
by antibodies specific for SNV.
Cellular localization of G1 and G2 proteins expressed
from the GPC clone
The intracellular maturation of the Old World hantavi-
ruses and other members of the family Bunyaviridae has
been attributed to the accumulation of the viral glycopro-
teins in the Golgi complex. To investigate the localization of
the glycoproteins in the New World hantaviruses, we ex-
pressed G1 and G2 glycoproteins from the IRES-GPC
clone, initially using the vTF7-3 expression system and
double-labeled indirect immunofluorescence microscopy.
As shown in Fig. 2A, polyclonal anti- SNV sera clearly
labeled the perinuclear Golgi-like region in transfected GPC
expressing NRK cells (left panel). Double staining with the
anti-SNV polyclonal sera and a monoclonal antibody
against mannosidase II, a Golgi marker, clearly show the
presence and retention of the expressed glycoproteins in this
region of the Golgi (right panel). In these experiments, even
after prolonged cycloheximide treatment (5 h), no cell-
surface staining was detected. To eliminate any possible
interference from the vaccinia infection, G1 and G2 proteins
were also expressed in the absence of vaccinia virus by
using BHK cells constitutively expressing T7 polymerase.
To enhance the stability of GPC mRNA, a polio-IRES was
placed in the construct between the T7 promoter and the
GPC open reading frame (IRES-GPC). Double-immunoflu-
orescence labeling using anti-SNV sera and anti-syntaxin-6
(a trans-Golgi marker) confirmed the Golgi localization of
the expressed glycoproteins (Fig. 2B). One of the main
advantages of using the BHK-T7 expression system over
the vaccinia-T7 transient expression system was the lack of
vaccinia-induced (CPE), which limits the extent of time
course possible. The transfected BHK-T7 cells remain in-
tact, allowing effects at later time points to be examined. In
cell-surface staining experiments using the BHK-T7 cells
transfected with IRES-GPC, accumulation of punctate
staining at the cell surface was detected at 24–36 h post-
transfection (Fig. 2C, left and middle panel). This staining
pattern was similar to that seen in the SNV-infected cells at
the later stages of the infection (Fig. 2C, right panel). Of
note was the formation of filopodia on the surface of cells
expressing the G1 and G2 (Fig. 2C, middle panel), indicat-
ing a possible involvement of actin (Laakkonen et al., 1998).
These results suggest that the majority of the viral gly-
coproteins of both the New and the Old World hantaviruses,
expressed from full-length GPC clones, are retained in the
Golgi complex (Pensiero and Hay, 1992; Ruusala et al.,
1992). However, the SNV-expressed glycoproteins reached
the cell surface after a prolonged period. It is unclear if
Fig. 1. Expression of full-length clones of G1, G2, and GPC in the vTF7-3 system. HeLa-T4 cells were infected with vTF7-3 and transfected with pGEM-G1,
pGEM-G2, and IRES-GPC. Cells were labeled with [35S]Cys at 12 h posttransfection for 1 h, chased for 1 h, and lysed. Protein samples were
immunoprecipitated and analyzed by SDS–PAGE. (A) Lysates from cells transfected with pGEM-G1 were immunoprecipitated using affinity-purified G1
antipeptide antibody (lane 2) or anti-SNV-specific polyclonal sera (lane 5). Also, lysates from cells transfected with pGEM-G2 were immunoprecipitated
using affinity-purified G2 antipeptide antibody (lane 3), or SNV-specific polyclonal rabbit serum (lane 4). Expressed G1 and G2 proteins comigrated with
authentic G1 and G2 synthesized in infected Vero-E6 cells and immunoprecipitated using anti-SNV-specific polyclonal serum (lane 7). Lanes 1 and 6
represent vTF7-3 lysates immunoprecipitated by using anti-G1 and anti-G2 antipeptide antibodies, respectively. (B) Lysates from cells transfected with
IRES-GPC following immunoprecipitation using G2 antipeptide antibody (lane 4), G1 antipeptide antibody (lane 5), and anti-SNV polyclonal sera (lane 6).
Lanes 1, 2, and 3 represent vTF7-3-infected cell lysates, immunoprecipitated using anti-G2, anti-G1, and anti-SNV sera, respectively. Lane 7 shows the GPC
clone expressed and processed to G1 and G2 glycoproteins that coimmigrate with the authentic G1 and G2 immunoprecipitated from SNV-infected Vero-E6
cells (lane 8), using the anti-SNV rabbit serum.
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cell-surface localization of the expressed glycoproteins is
also occurring in the Old World hantaviruses and other
members the family Bunyaviridae, as most studies with
these viruses have been limited to short time courses post-
transfection due to the cytopathic nature of the viral expres-
sion systems used.
Cellular localization of G1
After the confirmation of the Golgi localization of the
SNV glycoproteins expressed from the GPC clone, it was of
interest to see if the N-terminal glycoprotein (G1 for the
hantaviruses) was responsible for Golgi retention as has
been seen with other members of the family Bunyaviridae.
It was also hoped that these studies would shed light on the
earlier conflicting results obtained for localization of ex-
pressed HTNV G1 protein (Pensiero and Hay, 1992;
Ruusala et al., 1992). However, the initial results obtained
regarding the localization of SNV G1 expressed in the
absence of G2 were also puzzling. Immunofluorescence
experiments using the vaccinia vTF7-3 system to express
Fig. 2. Cellular localization of SNV G1 and G2 glycoproteins expressed from the full-length GPC clone. (A) Colocalization of G1 and G2 expressed from
the GPC clone with mannosidase II by immunofluorescence microscopy. NRK cells were infected with vTF7-3 and transfected with IRES-GPC. At 12 h
posttransfection, cycloheximide (50 g/ml) was added to the medium, and the cells were incubated at 37°C for 5 h and then were double stained with rabbit
anti-SNV sera (left) and monoclonal antimannosidase II (middle). The right panel shows the merge image of left and middle panel, in which yellow represents
overlap between red and green staining patterns. (B) Colocalization of G1 and G2 with syntaxin-6 in BHK-T7 cell line transfected with IRES-GPC construct.
At 36 h posttransfection, cells were fixed, permeabilized, and double stained using rabbit anti-SNV sera (left), and monoclonal anti-syntaxin-6 (middle). The
right panel shows the merge image of left and middle panels, and yellow represents overlap between red and green staining. (C) Cell-surface staining of the
expressed GPC at late stages posttransfection (left and middle panels). Vero E6 cells infected with SNV and labeled for surface staining at day 5 postinfection
are shown in the right panel.
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G1 showed an ER localization for G1 at early time points
posttransfection (Fig. 3a). At later times posttransfection,
the majority of the cells expressing G1 showed a prominent
juxtanuclear fluorescent pattern (Fig. 3b). Colocalization
experiments using double-immunofluorescence staining of
G1 and markers of the cis-, medial-, and trans-Golgi failed
to identify the G1 as a Golgi protein, and brefeldin A
treatment also failed to disrupt this Golgi-like staining (data
not shown). On the basis of these results, it appeared that the
majority of G1 expressed in the absence of G2 was localized
in the ER. However, at later time points when G1 was
overexpressed in cells, the G1- specific antipeptide antibody
detected G1 predominantly accumulating in defined struc-
tures in the proximity of the Golgi complex. Such structures
have been recently identified and called aggresomes (Gar-
cia-Mata et al., 1999; Kopito, 2000). Consistent with these
structures representing aggresomes, immunofluorescence
staining of an intermediate filament protein, vimentin,
shows its redistribution from filaments to ring-like forma-
tions in cells overexpressing G1 (data not shown). Vimentin
collapse such as this is a characteristic of aggresome for-
mation (Johnston et al., 1998).
To rule out possible influence of the vaccinia infection
on the aggresome formation, G1 was also expressed using
the IRES-G1 construct and the BHK-T7 cell line. The lo-
calization results however were the same as in vaccinia
vTF7-3 expression system. Anti-SNV polyclonal sera stain-
ing of the expressed G1 again showed a diffuse ER staining
Fig. 3. The SNV G1 protein expressed alone is not localized in the Golgi complex. HeLa-T4 cells were infected with vTF7-3 and transfected with a pGEM-G1
plasmid as described under Materials and methods. At 6 and 12 h posttransfection, panels a and b, respectively, cells were treated with 50 g of cycloheximide
and chased for 5 h. Cells were then fixed, permeabilized with Triton X-100, and stained with rabbit anti-G1 sera (a, b). Possible aggresome formation of G1
expressed in BHK-T7 cell line. Cells were transfected with IRES-G1 construct and at 24 h posttransfection were fixed, permeabilized, and double stained
using rabbit anti-G1 sera (c and f) and ER marker anticalnexin (d) or Golgi marker antisyntaxin-6 (g) as primary antibodies. Panels e and h show the merge
image of panels (c and d) and (f and g), respectively.
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(data not shown). G1 antipeptide sera preferentially showed
a juxtanuclear fluorescent pattern of the expressed G1 which
was next to, but did not colocalize with, markers of ER
(calnexin) (Fig. 3e), or Golgi (syntaxin-6) (Fig. 3h). Unlike
the G1 expressed from the GPC precursor, G1 expressed in
the absence of G2 showed no convincing cell-surface stain-
ing even at late posttransfection time points (data not
shown). SNV G2 localizes to the ER when expressed in the
absence of G1, as expected based on previous HTNV stud-
ies (Pensiero and Hay, 1992; Ruusala et al., 1992), and even
when G1 and G2 are coexpressed but from separate plas-
mids (data not shown). This result further emphasizes the
importance of G1 and G2 expression from a full-length
GPC ORF to obtain authentic protein folding and traffick-
ing.
In parallel with the above immunofluorescence experi-
ments, immunoprecipitation experiments were also per-
formed at different times (5, 12, and 16 h) posttransfection,
followed by a chase period of 5 h. The G1 protein expressed
in the absence of G2 was detected in both monomeric and
multimeric forms at the 5 h time point (Fig. 4, lane 3), a time
corresponding to G1 being localized in the ER (Fig. 3a),
whereas only multimeric forms were seen at later time
points (Fig. 4, lanes 5, and 7), which may correspond with
the G1 protein being located in the aggresomes (Fig. 3b).
The oligomeric high molecular forms of G1 are stable,
consistent with previous reports which demonstrated the
stability of proteins within aggresomes (Johnston et al.,
1998). In comparison, a time course of the expression of the
G2 (expressed in the absence of G1) was also included in
this experiment. G2 was detected as a doublet band (Fig. 4,
lane 4), representing the unglycosylated and glycosylated
forms of the protein (Spiropoulou, 2001). The G2 protein
predominantly shifts to the glycosylated form (the upper
band) by the 12 and 16h time points (Fig. 4, lanes 6 and 8).
In contrast to the G1 protein, no G2 protein multimers were
detected.
It appears, then, that SNV G1 expressed in the absence of
G2 could be detected intracellularly in the ER, as has been
shown in one of the previous studies for HTNV G1
(Ruusala et al., 1992). However, G1 has the tendency to
form SDS stable oligomers and it can be found in what
seems to be aggresome formations at later time points when
overexpressed. These structures are most clearly seen when
staining with the G1-specific antipeptide antibody and struc-
tures such as these could have been misidentified as the
Golgi complex in earlier studies (Kopito, 2000).
Localization of G1 and G2 in SNV-infected cells
Endothelial cells play an important role in SNV-infected
patients. During infection the majority of virus antigen is
expressed in these cells, and endothelial cell leakage is a
prominent feature of HPS (Zaki et al., 1995). For this
reason, we included both primary lung endothelial cells
(HMVEC) and Vero E6 cells (the cell line most commonly
used to propagate hantaviruses) in studies to examine the
correlation between SNV glycoprotein trafficking in in-
fected cells and that observed in our studies using plasmid
expression systems. Vero E6 and HMVEC cell lines were
infected with SNV, and a double-label indirect-immunoflu-
orescence assay was performed using the anti-SNV poly-
clonal antibody and antibodies specific for the ER and
Golgi. The observed staining with anti-SNV polyclonal sera
was well defined in the Golgi region (Fig. 5). Although the
anti-SNV sera recognized the N protein in addition to the
G1 and G2 proteins, the observed Golgi pattern represents
mainly the G1 and G2 proteins, as a completely different
pattern is observed when an N-specific monoclonal anti-
body is used (see Fig. 9B, panel a). A punctate staining
throughout the cytoplasm could be seen at late time points,
but these did not costain with any Golgi markers and there-
fore did not represent dispersed Golgi elements. The late
punctate cytoplasmic staining could represent sites of in-
creased expression of N protein. Although results are shown
only for the primary endothelial cell line, similar results
were observed with the Vero E6 cells (data not shown). In
addition, cell-surface staining was also detectable late in
infection in these endothelial cells, similar to that observed
in SNV-infected Vero E6 cells (Fig. 2C, right panel).
On the basis of the above results, it appears that the G1
and G2 proteins accumulate initially in the Golgi apparatus
when expressed in both natural SNV infections and in
transient expression systems using GPC encoding plasmids.
At late stage post-SNV infection or GPC transfection, the
glycoproteins can be detected on the cell surface.
An additional pool of G1 exists outside the Golgi complex
in SNV-infected cells
Recently, a number of Fabs were generated from a phage
display library constructed by using RNA extracted from
bone marrow of an SNV-infected convalescent-phase pa-
Fig. 4. Time course of expression of G1 and G2 in HeLa-T4 cells using the
vTF7-3 transient system. HeLa-T4 cells were infected with vTF7-3 and
transfected with the pGEM-G1 and pGEM-G2 plasmids. At 5, 12, or 16 h
posttransfection, the cells were labeled with [35S]Cys for 1 h, chased for
another 5 h, and immunoprecipitated using the rabbit anti-SNV sera. Lanes
3, 5, and 7 show the immunoprecipitation of the expressed G1 at time
points 5, 12, and 16 h. Lanes 4, 6, and 8 show the immunoprecipitated G2
at the time points 5, 12, and 16 h, respectively. Lanes 1, 2, and 9 represent
the vTF7-3 controls at the equivalent time points. MWM, high molecular
weight markers.
53C.F. Spiropoulou et al. / Virology 308 (2003) 48–63
tient (P.W. Parren and D.R. Burton, unpublished data). The
panning of the Fab library was done by using SNV-infected
Vero E6 cells as the antigen source. The Fab used in this
study, SNV-26, was also engineered to a complete human
IgG1. Immunofluorescence studies using Fab SNV-26 show
that it does not react with uninfected cells (Fig. 6B, panel a),
but specifically recognizes the G1 glycoprotein as shown by
immunoprecipitation experiments, using SNV-infected cell
lysates (Fig. 6A). Interestingly, the G1 localization seen in
immunofluorescence experiments using the Fab SNV-26
(Fig. 6B, panel b) was quite different to that seen previously
when using anti-SNV polyclonal sera (Fig. 5). G1 stained
with Fab SNV-26 did not localize with the Golgi in SNV-
infected cells (Fig. 7A) or GPC expressing transfected
BHK-T7 cells (Fig. 7B). From the punctate staining pattern
observed with Fab SNV-26, it was apparent that a popula-
tion of G1 also accumulates in an additional intracellular
compartment distinct from the Golgi complex.
To examine in more detail the interaction of SNV-26
antibody with G1, we tested the ability of the Fab to rec-
ognize hantaviruses other than SNV. Surprisingly, SNV-26
also cross-reacted with other New World hantaviruses and
Old World hantaviruses, including Andes, Black Creek Ca-
nal, Hantaan, Seoul, Dobrava, and Prospect Hill viruses
(data not shown). Analysis of the amino acid sequences of
the G1 glycoprotein revealed that one of the most highly
conserved areas was a 12 amino acid region of the ectodo-
main adjacent to the transmembrane domain. To map the
recognition domain, a series of plasmids encoding SNV G1
deletion mutants was constructed (Fig. 8A). The deleted
forms of G1 were shown to be efficiently expressed from
each of the plasmids (Fig. 8B). SNV-26 was found to still
Fig. 5. Accumulation of the virus structural proteins in the Golgi compartment. Primary lung endothelial cells grown on glass coverslips were infected with
SNV and fixed at day 1 (a, b, c) or day 5 (d, e, f, g, h, i, j, k, m) postinfection. On the left, panels a, d, g, and j were stained using anti-SNV polyclonal sera.
In the middle, various cellular compartments were stained with the following antibodies: ER, anti-calnexin (b); cis-Golgi, anti-P58 (e); Golgi, anti- syntaxin-6
(h); TGN, anti-AP-1 (k). On the right, panels c, f, i, and m are the merge images of (a, b), (d, e), (g, h), and (j, k), respectively, and yellow represents overlap
between red and green staining.
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react with the form of G1 which represented the amino-
terminal 455 amino acids and included deletion of the cy-
toplasmic tail and most the transmembrane domain (see
G1–455, Fig. 8C). However, further deletion of amino acids
443 to 455 resulted in loss of recognition (see G1–442, Fig.
8C). As a positive control, the various truncated forms of
G1 remained detectable with a G1 antipeptide antibody
which recognizes the amino-terminus of G1 (Fig. 8C). The
region, amino acids 443 to 455, contains the highly con-
served amino acids adjacent to the transmembrane domain.
Thus, the results of the mapping experiments were consis-
tent with SNV-26 cross-reactivity with other hantaviruses
and G1 amino acid conservation analysis.
A population of G1 is colocalized with Lamp-1, a late
endosomal-lysosomal resident protein
On the basis of the punctuate immunofluorescent pattern
of the G1 detected by the Fab antibody, additional double-
immunofluorescence experiments were performed with
SNV-infected endothelial cells, this time using endosomal–
lysosomal markers and antibodies to the SNV N protein. No
convincing evidence of colocalization of G1 with EEA1, an
early endosomal marker (Fig. 9A, panels a, b, and c), or the
N protein (Fig. 9B, panels a, b, and c) was found. In
contrast, an extensive overlap of the G1 staining with that of
Lamp-1, a late endosomal-lysosomal marker, was detected
(Fig. 9A, panels d, e, and f). To clearly show that G1
colocalizes with Lamp-1, EM studies were performed on
SNV-infected endothelial cells (Fig. 10). Immunogold la-
beling using the SNV-26 IgG1 demonstrated that G1 was
present in intracellular dense vesicles. Double-immunogold
labeling using both SNV-26 IgG1 and Lamp-1 specific
antibody showed that G1 is contained within intracellular
vesicles that possess Lamp-1 in their membranes. These
vesicles represent late endosomal–early lysosomal struc-
tures.
Discussion
The initial objectives of these studies were to attempt to
express the SNV G1 and G2 glycoproteins in a mammalian
expression system, to clarify their site of cellular localiza-
tion, and to compare their trafficking with that of G1 and G2
synthesized during SNV infection.
The first step of the project, the cloning of the full-length
GPC of SNV, was quite challenging, which was not unex-
pected given the history of constructing different hantavirus
M segment clones (Bharadwaj et al., 1999; Hooper et al.,
2001; Spiropoulou, 2001). To date, reports of expression of
the two SNV glycoproteins involved only fragments of GPC
(Bharadwaj et al., 1999; Jenison et al., 1994). By studying
the localization of the G1 and G2 expressed from the GPC
clone, it was expected that an indirect answer might be
obtained for the site of virus maturation, since Golgi mat-
Fig. 6. Fab SNV-26 recognizes the G1 glycoprotein. (A) SNV-infected Vero E6 cells were labeled for 3 h with [35S]Cys at day 5 postinfection, lysed,
immunoprecipitated, and analyzed by SDS–PAGE. Cell lysates were immunoprecipitated using SNV-26 IgG1 (middle lane) and anti-SNV polyclonal sera
(right lane). The control in left lane represents uninfected Vero E6 cell lysates immunoprecipitated with anti-SNV-26 IgG1. (B) Primary lung endothelial cells
were used as an uninfected control (a) or were infected with SNV (b). The cells were fixed at day 5 postinfection and indirect immunofluorescence assay
performed using SNV-26 IgG1 as the primary antibody.
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Fig. 7. Absence of colocalization of the G1 detected with Fab SNV-26 with Golgi markers. (A) Primary lung endothelial cells grown on glass coverslips were
infected with SNV and fixed at day 1 (panels a, b, c,) or day 5 (panels d, e, f, g, h, i, j, l, k) postinfection. On the left, panels a, d, g, j were stained using
Fab SNV-26. In the middle, various cellular compartments were stained with the following antibodies: ER, anti-calnexin (b); cis-Golgi, anti-P58 (e); Golgi,
antisyntaxin- 6 (h); TGN, anti-AP-1 (l). On the right, panels c, f, i, and k are the merge images of (a, b), (d, e), (g, h), and (j, l), respectively. (B) G1 expressed
from the GPC clone and detected with Fab SNV- 26 does not localize in the Golgi. BHK-T7 cells were transfected with IRES-GPC construct. At 24 h
posttransfection cells were fixed, permeabilized, and double stained using Fab SNV-26 (left) and antisyntaxin-6 (middle). Right panel shows the merge image
of the left and middle panels.
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uration for viruses of the family Bunyaviridae has been
thought to be due to the retention and accumulation of the
two viral glycoproteins G1 and G2 in the Golgi complex
(Pettersson and Melin, 1996). For the hantaviruses in par-
ticular, it had been previously shown for HTNV (which the
literature suggests matures in the Golgi complex) that GPC-
expressed G1 and G2 glycoproteins are localized in the
Golgi and do not reach the cell surface (Pensiero and Hay,
1992; Ruusala et al., 1992).
As expected on the basis of these earlier HTNV GPC
studies, in our SNV glycoprotein studies using the vTF7-3
system in two different cell lines (Hela-T4 and NRK) we
were also able to show that G1 and G2 proteins expressed
from the GPC clone accumulated in the Golgi complex and
were not detected at the cell surface. However, expression
of the IRES-GPC clone in the BHK-T7 cell line had the
advantage of expressing the glycoproteins in intact cells for
a prolonged period. In this expression system, cell-surface
localization of the viral glycoproteins was detected at late
time points. These results may be interpreted as SNV and
HTNV glycoproteins trafficking differently, which is pos-
sible given the low extent of amino acid identity between
these glycoproteins, 68% for the G1 and 80% for the G2
(Spiropoulou et al., 1994). However, the results may simply
reflect the difference in the expression systems used. Be-
cause the HTNV studies were done only using cytopathic
viral expression vectors, it will be interesting to see if
cell-surface localization of the expressed HTNV glycopro-
teins is observable at later time points using noncytopathic
expression systems.
Contrary to our initial expectations, our results clearly
demonstrated that the majority of SNV G1 expressed in the
absence of G2 accumulated in the ER and did not transit to
the Golgi. With the G1 encoding plasmid, at later time
points posttransfection when G1 is overexpressed, G1 also
accumulated into structures likely to represent aggresome
formations. G1 possesses extensive hydrophobic regions
that normally should be embedded in the lipid bilayer or
interact with the G2 protein (Spiropoulou, 2001). It is pos-
sible that exposure of these hydrophobic regions to the
cytosolic environment may lead to nonnative conformations
and to the accumulation of misfolded G1 aggregates in the
aggresome. Consistent with this, G1 expressed in the ab-
sence of G2 was found to form stable SDS-resistant mul-
timers at all time points analyzed. The region of G1 respon-
sible for the multimer formation has been mapped on the
Fig. 8. Detection of the G1 region recognized by Fab SNV-26. (A) Schematic representation of the constructs encoding the full-length G1 and truncated G1
mutants (numbers on the G1 truncation mutants refer to the amino acids included). (B) Expression of the G1 truncation mutants in the vTF7-3 system.
HeLa-T4 cells were infected with vTF7-3 and transfected with plasmids expressing G1 and mutants G1–445, G1–521, G1–499, G1–442, G1–413. At 12 h
posttransfection, the cells were labeled with [35S]Cys for 1 h, chased for another 1 h, lysed, and immunoprecipitated using the G1-specific antipeptide
antibody as described under Materials and methods. (C) HeLa-T4 cells were infected with vTF7-3 and transfected with G1 and G1 truncation mutant
expressing plasmids. At 12 h posttransfection, cells were fixed, permeabilized, and stained using Fab SNV-26 antibody (top) or G1 antipeptide antibody
(bottom). G1 truncation mutants G1–442 and G1–413 show staining with control G1 antipeptide antibody, but not with SNV-26.
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second part of the hydrophobic domain at amino acids
500–520 (C.F. Spiropoulou et al., unpublished data). The
accumulation of SNV G1 in the aggresome may have no
biological significance, since it is only seen when G1 is
expressed in the absence of G2 and is not seen in SNV-
infected cells or when G1 is expressed via the GPC precur-
sor. However, it may be important for explaining earlier
reported discrepancies relative to HTNV G1 trafficking.
The trafficking of the glycoproteins expressed from the
GPC-encoding plasmid corresponded well with the traffick-
ing of the glycoproteins in SNV-infected cells. In cell in-
fections, we included human primary lung endothelial cells
which are thought to be the target cells during natural virus
infection, in addition to Vero E6 cells, which are the cell
lines most commonly used for hantavirus studies (Zaki et
al., 1995). The Golgi localization of the SNV glycoproteins
Fig. 9. Colocalization of G1 detected by the Fab SNV-26 with Lamp-1 a late endosomal lysosomal marker. (A) Primary lung endothelial cells were infected
with SNV and fixed at day 5 postinfection. Panels a and d show immunostaining of G1 using as primary antibody Fab SNV-26. Panels b and e show
immunostaining using markers of the endocytotic pathway: anti-EEA1 (b) and anti-Lamp- 1 (e). Panels c and f are the merge image of (a, b) and (d, e),
respectively. Yellow represents overlap between red and green staining patterns. (B) Absence of colocalization of G1 detected by the Fab SNV-26 with N
protein. Double-immunofluorescence staining was performed as described previously. Panel a shows immunostaining of N using as primary antibody the
N-specific monoclonal GB04-BF07; panel b shows immunostaining of G1 using as primary antibody Fab SNV-26 and panel c shows double staining using
both antibodies. Note the distinctive pattern of punctuated staining of N protein in the infected cells.
58 C.F. Spiropoulou et al. / Virology 308 (2003) 48–63
was prominent during the course of the infection in both cell
lines, and cell-surface expression of the glycoproteins, as in
the BHK-T7 GPC expression system, was detectable late in
infection.
These data obtained by using the GPC expression system
provide some insight into the site of virus maturation. We
clearly showed that G1 and G2 expressed in virus-infected
cells or expressed from GPC-encoding plasmids predomi-
nantly accumulate in the Golgi. This finding, together with
the fact that the N protein is also localized in the Golgi
(Ravkov and Compans, 2001), suggests that the glycopro-
teins recruit viral cores to the Golgi where virus maturation
takes place. On this matter it would be of interest to deter-
mine if the N protein in the Golgi is in the form of ribo-
nucleocapsid by using virus N riboprobes in future in situ
hybridization EM studies. However, we also showed that at
late times following either virus infection or GPC transfec-
tion, virus glycoprotein is detectable at the cell surface.
These results could be considered consistent with those of
EM studies, which predominantly detect virus particles at
the cell surface, but only rarely in the Golgi (Goldsmith et
al., 1995). Further studies will be needed to resolve this
issue. Such studies should include representatives of both
Old and New World hantaviruses to firmly establish
whether major differences exist among members of the
hantavirus genus at the level of virus assembly and release.
The use of a SNV G1-specific Fab SNV-26 produced
from a convalescent-phase SNV-infected HPS patient
proved very interesting. This antibody was surprisingly
cross-reactive with other New World and Old World han-
taviruses. One of the most highly conserved regions of
hantavirus G1 proteins is located in an approximately 12
amino acid region of the ectodomain adjacent to the trans-
membrane domain. Our mapping experiments confirmed
that this is the region of SNV G1 recognized by SNV-26.
No precise function has been ascribed to this region, but the
high amino acid conservation seen among the diverse mem-
bers of the hantavirus group would suggest this region plays
a central role in the virus life cycle. SNV-26 detects a large
fraction of G1 which colocalized with Lamp-1, a late en-
dosomal–lysosomal membrane protein. Similar results were
obtained whether G1 was expressed in the GPC-encoding
plasmid transfection experiments or in SNV-infected endo-
thelial or Vero E6 cells. This may represent Fab SNV-26
recognition of misfolded G1 accumulating in the lysosomes.
However, Fab SNV- 26 may detect a conformational form
of G1 that is induced at acidic pH, such as that found in
lysosomal vesicles. Interestingly, Lamp-1 itself is known to
Fig. 10. Immunoelectron microscopic analysis of SNV G1 colocalization with Lamp- 1. EM labeling of SNV-infected primary lung endothelial cells at day
5 postinfection with SNV- 26 IgG1 and Lamp-1. (A) Structures that are labeled for G1 (12-nm gold, arrowheads). (B) Area with extensive label for G1 (12-nm
gold, arrowheads) that is also labeled with Lamp-1 (6-nm gold, arrows). Bars, 100 nm.
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traffic to the trans-Golgi, from which the majority goes on
to the lysosomes and a minority goes to the cell surface, and
recycles between the trans-Golgi network and plasma mem-
brane (Rohrer et al., 1996). The peptide motif contributing
to the Lamp-1 trafficking to lysosomes is GYxxL at the end
of its cytoplasmic tail (Gough et al., 1999). A tyrosine-based
motif YxxL also exists at the end of the long cytoplasmic
tail of SNV G1 at position 618Y. This motif is present, and
highly conserved, in the G1 cytoplasmic tail of both New
World and Old World Hantaviruses. As SNV G1 has an
intrinsic tendency to aggregate, it is also possible that pro-
gressive accumulation of G1 in the trans-Golgi network
(TGN) could result in its aggregation and delivery to the
lysosomes for degradation (Wolins et al., 1997). Interest-
ingly, early endosomes and lysosomes have also recently
been implicated in the process of HTNV virus entry (Jin et
al., 2002).
Presumably, the G1 that accumulates in the late endo-
somes–lysosomes is destined for degradation. Degradation
of the lysosomal population of G1 could possibly explain
the unequal amounts of G1 observed relative to G2 in
immunoprecipitation experiments. It will be of interest in
future studies to determine the turnover rate of G1 in the
presence or absence of inhibitors of lysosomal proteolysis.
As the YxxL motif has also been implicated in the internal-
ization of surface glycoproteins (Ohno et al., 1995; Tira-
bassi and Enguist, 1999), this motif may contribute to re-
cycling of the hantavirus glycoproteins between the cell
membrane and TGN and would provide an explanation for
the cell-surface expression of SNV glycoproteins seen late
in virus infection or transfection with the GPC-encoding
plasmid. Interestingly, the same motif is also present at the
carboxy-end of the Crimean–Congo hemorrhagic fever vi-
rus G2 protein (equivalent to SNV G1), but not in the
equivalent glycoproteins of Rift Valley fever, Uukuniemi,
and Punta Toro viruses. Experiments are planned to exam-
ine potential recycling of the SNV glycoproteins expressed
during virus infection or in transfection experiments in
which GPC is expressed. The YxxL motif has been also
reported to constitute part of the binding site for cellular
proteins that may be involved in virus budding. For exam-
ple, in the equine infectious anemia virus Gag protein, a
YxxL motif was shown to mediate interaction with a com-
ponent of the endocytotic pathway AP2 protein (Puffer et
al., 1998). Therefore, it is possible that YxxL could also
function in a similar way by recruiting the appropriate
cellular proteins to the SNV budding site.
In summary, these results clearly suggest that the SNV
G1 protein, when expressed from GPC, can follow at least
two distinct pathways: one that leads to the formation of a
noncovalent G1/G2 complex and its Golgi localization, and
another that leads to the delivery of G1 glycoprotein to the
lysosomes. It appears plausible that the first is the produc-
tive pathway which results in virion formation, whereas the
second is a nonproductive pathway leading to degradation
of the virus glycoproteins. This second pathway could rep-
resent a mechanism by which hantaviruses down regulate
glycoprotein levels and virus maturation. One of the hall-
marks of hantavirus maintenance in its primary rodent host
species is the establishment of a persistent infection that
lasts most of the life of the rodent (Yanagihara et al., 1985).
It is possible that down regulation of virus glycoproteins
and virus-particle formation could play a role in the mech-
anism of virus persistence in the rodent reservoir, in addi-
tion to other mechanisms previously suggested (Meyer and
Schmaljohn, 2000).
Material and methods
Cells, RNA, and viruses
HeLa-T4, Vero E6, CV-1, baby hamster kidney (BHK-
21), and normal rat kidney (NRK) cells were maintained in
monolayer culture in Dulbecco’s minimal essential medium
(DMEM) supplemented with 10% fetal bovine serum
(FBS). Primary human pulmonary macrovascular endothe-
lial cells (HMVEC-L), obtained from Clonetics (Walkers-
ville, MD), were maintained in EGM-2MV growth media
(Clonetics). BHK-T7, a cell line that constitutively ex-
presses the T7 polymerase, was provided by K-Klaus Con-
zelmann, Max V. Pettenkofer-Institut Fur Virologie, Mu-
nich, Germany. Total RNA was extracted from virus-
infected Vero E6 cells (for the completion of the GPC
plasmid) or lung tissue of a HPS (H10) patient as described
previously (Spiropoulou et al., 1994). The recombinant vac-
cinia virus vTF7-3 (Fuerst et al., 1986) was provided by B.
Moss (National Institutes of Health, Bethesda, MD). The
vTF7-3 was grown on HeLa T4 cells, and the virus titers
were determined on CV-1 cells. SNV was grown and titered
on Vero-E6 cells. All work with infectious SNV was per-
formed in a biosafety level 3 laboratory.
Antibodies
Rabbit polyclonal antiserum against SNV-infected cells
that recognizes the viral glycoproteins as well as the capsid
protein was provided by T. G. Ksiazek. G1 expression was
also detected with affinity-purified antipeptide antibody
G1 (targeting amino acids 72–91, TTTQKYNQVDWT-
KKSSTTE). The target of the G1 antibody partially over-
laps with a linear epitope detected in previous studies (ami-
no acids 59 to 84) (Jenison et al., 1994). G2 expression was
detected with affinity-purified antipeptide antibody G2 (tar-
geting amino acids 690–704, YSYRRKLVNPANQEET).
Human Fab SNV-26 and the whole human IgG1(SNV-26)
were engineered by using a phage display library from RNA
extracted from bone marrow of an HPS-convalescent pa-
tient and were provided by Paul Parren and Dennis Burton.
Antibodies used as markers for different cellular compart-
ments were monoclonal antimannosidase II (rat-specific)
(BAbCO, Richmond, CA); monoclonal anti-syntaxin-6 and
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monoclonal anti-Early Endosomal- Antigen 1 (EEA1), (BD
Transduction Laboratories, Lexington, KY); monoclonal
antiadaptin (AP1) clone 100/3, monoclonal antivimentin,
and monoclonal anti-Golgi 58K protein (Sigma, St. Louis,
MO); monoclonal anticalnexin (Affinity BioReagents,
Golden, CO); and monoclonal anti-Lamp-1 (Research Di-
agnostics, Flanders, NJ). Secondary antibodies were fluo-
rescein isothiocyanate (FITC)-conjugated goat anti-rabbit
IgG, tetramethyl rhodamine isothiocyanate- (TRITC)-con-
jugated goat anti-mouse IgG, and FITC-conjugated anti-
human (Fab)2 (Sigma).
Construction of recombinant plasmids for expression
studies
The SNV G1 gene fragment was generated as previously
described (Ennis et al., 1997). The full-length G2 gene
fragment potentially encoding the G2 glycoprotein was re-
verse transcribed and amplified by polymerase chain reac-
tion (PCR) (Perkin–Elmer Cetus). The fragment was cloned
using the oligonucleotide primers G1953() (with sequence
5GGAATAGGATCCAGTATGGGAATTCTTTTAACA-
ACTGAA 3 having a BamH1 site and the AUG intro-
duced) and G3495() (with sequence 5GGTGGCTG-
CAGTCTTGCTCACATATATATTCACTAATTAGC 3).
A series of G1 truncation mutants was generated by PCR
amplification of the G1 plasmid, using the same 5- primer
as originally used for the G1 amplification (Ennis et al.,
1997). A termination codon (boldface) and the EcoRI re-
striction site (underlined) were added to the 3-prime end
primers. The 3-end primer sequence for the G1–521 mu-
tant was 5AACGGAGAATTCTTAGAAAGTGAGCAA-
CCTCAGGAT3; G1–499 mutant was 5AACGGAGAAT-
TCTTAAAGGAGCCAGCCAAAGCAAAA3; G1– 455
mutant was 5AACGGAGAATTCTTAAATGCATTGGC-
CTATGACCAG3; G1–442 mutant was 5AACGGAGA-
ATTCTTACTTTTGTCCATTACAATAGACAACT3; and
G1–413 mutant was 5AACGGAGAATTCTTATTGAA-
CTTTATTCACTAGAC3. The PCR products were puri-
fied using a Geneclean kit (Bio 101, La Jolla, CA), protein-
ase K digested, phenol-chloroform extracted, and ethanol
precipitated. The products were then digested with the ap-
propriate restriction enzymes and cloned into the plasmid
pGEM-3Z (pGEM-G1 and pGEM-G2 encoding for the G1
and G2 protein, respectively) and pGEM-4Z (for the G1
mutants) using standard protocols.
A full-length cDNA for the GPC open reading frame was
constructed initially in the pSINrep5 replicon (Invitrogen,
Carlsbad, CA) by ligating the full-length repG1 with the
Sph1-Apa1 fragment of G2 (G2 lacking 196 nt of the 5
terminus). The plasmid for the GPC construct was com-
pleted by inserting a 771-bp fragment using the restriction
sites Spe 1 (position 1432 nt on the M segment) and Sph1
(position 2203 nt). Full-length GPC was transferred into a
pSP64 poly(A) vector (Promega, Madison, WI) containing a
polio-IRES fragment (830 nt) downstream of a T7 promoter
(T7-IRES was provided by Bert L. Semler, U.C. Irvine). In
addition, the full-length G1 was also subcloned into the
pSP64 poly(A) vector containing the polio-IRES. The plas-
mids were transformed and propagated in SURE-competent
cells (Stratagene, La Jolla, CA) to minimize the possibility
of recombination. Plasmid DNAs were then purified with
maxi-prep Qiagen column and the correct orientation of the
inserts and the precise nucleotide sequence were verified by
dideoxynucleotide sequence analysis.
Expression of G1 and G2 constructs by using the
vaccinia-T7 transient expression system
Subconfluent monolayers in 35-mm dishes of HelaT4 or
NRK cells were infected with recombinant vaccinia virus
expressing the T7 polymerase gene (vTF7-3) at a multiplic-
ity of infection (m.o.i.) of 5 for 1 h and washed with
serum-free medium Opti-MEM (Life Technologies, Gaith-
ersburg, MD). Plasmid DNAs (5 g) were mixed with 15 l
of lipofectin (Life Technologies) 700 l Opti-MEM me-
dium and added to the vaccinia-infected cells. After a 4 h
incubation at 37°C, 300 l of DMEM containing 10% FCS
was added and the incubation was continued for 6 or 12 h
posttransfection.
Cell radiolabeling and immunoprecipitation
Transfected HeLa T4 cells were labeled with 100 Ci/ml
[35S]Cys (G1 and G2 are cysteine-rich proteins having a
total of 57 cysteines) in cysteine-free MEM for 1 h, at
indicated times posttransfection. Cells were harvested in
radioimmunoprecipitation assay (RIPA) buffer [150 mM
NaCl, 1.0% Triton X-100, 1% deoxycholate (DOC), 0.1%
sodium dodecyl sulfate (SDS), 1 mM EDTA, 10 mM Tris,
pH 8.0], 1% aprotinin, 2 mM phenylmethylsulfonylfluoride
(PMSF), 1 g/ml leupeptin, and 1 g/ml pepstatin. When
antipeptide antibodies were used for immunoprecipitation,
the cells were harvested in RIPA buffer containing 1% SDS
and 1% 2-mercaptoethanol, and the cell lysate was diluted
1:10 before the addition of the antibody. The final amount of
the cell lysate used in immunoprecipitations with the anti-
peptide antibodies was one-fourth of that used with the SNV
polyclonal sera. The cell lysates were added to the anti-
body–protein A Sepharose (Sigma) complex for 3 h at 4°C
and washed three times with RIPA buffer. The protein
samples were heated at 37°C for 15 min in Laemmli loading
buffer before analysis on 7 or 10% SDS–polyacrylamide
gels (Nakitare and Elliott, 1993). Fluorography and autora-
diogram exposure of dried gels were carried out by standard
techniques.
Immunofluorescence
HeLa-T4 and NRK cells grown on coverslips were in-
fected with vTF7-3 at an m.o.i. of 1 and were transfected
with the recombinant plasmid DNA. At various times post-
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transfection, the cells were treated with cycloheximide (50
g/ml) for 5 h. BHK-T7 cells were transfected only with
recombinant constructs IRES-GPC and IRES-G1. Vero E6
cells and primary endothelial cells were infected with SNV
at an m.o.i. of 0.5. At certain times posttransfection or
postinfection, cells were washed twice with phosphate-buff-
ered saline (PBS) and fixed with 2% formaldehyde or ace-
tone at room temperature for 10 min. After formaldehyde
fixation, the cells were washed three times with PBS and
either permeabilized with 0.1% Triton X-100 for intracel-
lular fluorescence or left untreated for surface immunoflu-
orescence. The primary antibody was added at a 1:200
dilution in 1% bovine serum albumin (BSA) in PBS for 30
min. The cells were then washed three times with PBS and
incubated for 30 min with FITC- conjugated goat anti-rabbit
IgG (Sigma), diluted 1:200 in 1% BSA in PBS. For double
staining, cells were incubated with antibodies to viral pro-
teins together with monoclonal antibodies to intracellular
markers and stained with FITC-conjugated goat anti-rabbit
IgG diluted 1:200, anti-human IgG(Fab-specific) FITC-con-
jugated diluted 1:200, and TRITC-conjugated goat anti-
mouse IgG (Sigma) diluted 1:80 in 1% BSA in PBS. Mul-
tiple final washes were done and the cells were mounted on
microscope slides and viewed by using a Zeiss microscope.
Immunogold EM
Endothelial cells (HMVEC) uninfected or infected at an
m.o.i. of 1 were fixed at 5 days postinfection with phos-
phate-buffered 1.5% paraformaldehyde and 0.025% glutar-
aldehyde for 2 h. After fixation, the cells were irradiated
with 2  106 rad of gamma from a cobalt source and then
processed as described previously (Goldsmith et al., 1995).
Antibodies used in the EM experiments were human Fab
SNV-26 engineered to whole IgG1 molecule for detection
of the virus and monoclonal anti-Lamp-1. Goat anti-mouse
conjugated to 6 nm colloidal gold particles and goat anti-
human conjugated to 12 nm colloidal gold particles (Jack-
son ImmunoResearch Laboratories, West Grove, PA) were
used as secondary antibodies.
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